Roche’s Small Deal Has Big Cancer Promise

Bookmark
(Bloomberg Opinion) -- When it comes to this month’s dealmaking in biotech, the record $74 billion takeover of Celgene Inc. by Bristol-Myers Squibb & Co. has been the focus of attention. A smaller ...
BQ Install

Bloomberg Quint

Add BloombergQuint App to Home screen.